Literature DB >> 27344198

Misuse of OTC drugs in Poland.

Tomasz Zaprutko1, Dorota Koligat2, Michał Michalak3, Marta Wieczorek4, Malwina Józiak4, Monika Ratajczak4, Kinga Szydłowska4, Joanna Miazek4, Krzysztof Kus2, Elżbieta Nowakowska2.   

Abstract

INTRODUCTION: The misuse of over-the-counter (OTC) drugs became a global public health concern. Although abuse with dextrometorphan (DXM), pseudoefedrine (PSD), codeine (COD) or benzydamine (BND) may lead even to psychosis, drugs containing these substances are relatively cheap and freely available. In Poland the Act on Counteracting Drug Addiction was amended in 2015, however it seems that there are still some points which could be improved.
METHODS: Study was conducted between October 2014 and June 2015 using a specially designed questionnaire delivered to pharmacists from the Greater Poland region. Questionnaire consisting of 11 closed questions was distributed by direct contact and via the Internet. From over 2500 distributed questionnaires, we received 761 sheets and 680 were included.
RESULTS: The misuse of OTC drugs is increasing in Poland from pharmacists point of view. The most popular substance was PSD followed by COD and DXM. The main reason of misuse of these drugs could be related to the use of Internet and free access to these medications. In respondents (58.2%) opinion OTC drugs containing analyzed substances should be moved into the prescription status.
CONCLUSIONS: The misuse of OTC drugs should be considered as a very dangerous phenomenon. Although the Act on Counteracting Drug Addiction was amended in Poland in 2015, there are some facets requiring improvement. Social education may play a key role in the limitation of misuse of OTC drugs.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Law; Misuse; OTC drugs; Pharmacists’ opinions; Poland

Mesh:

Substances:

Year:  2016        PMID: 27344198     DOI: 10.1016/j.healthpol.2016.06.008

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  4 in total

1.  Facebook as a source of access to medicines.

Authors:  Tomasz Zaprutko; Dorota Kopciuch; Anna Paczkowska; Józefina Sprawka; Julia Cynar; Monika Pogodzińska; Katarzyna Niewczas; Aleksandra Stolecka; Maria Sygit; Michał Michalak; Piotr Ratajczak; Krzysztof Kus
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

2.  Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

Review 3.  In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine.

Authors:  Antonio Munafò; Stefano Frara; Andrea Giustina; Renato Bernardini; Norberto Perico; Rosaria Di Mauro; Monica Cortinovis; Chiara Burgaletto; Giuseppina Cantarella; Giuseppe Remuzzi
Journal:  Rev Endocr Metab Disord       Date:  2021-05-04       Impact factor: 6.514

4.  The Benzydamine Experience: A Systematic Review of Benzydamine Abuse.

Authors:  Chiappini Stefania; Miuli Andrea; Mosca Alessio; Pettorruso Mauro; Guirguis Amira; Corkery John Martin; Martinotti Giovanni; Schifano Fabrizio
Journal:  Curr Neuropharmacol       Date:  2021-10-18       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.